Effect on Blood Lipids and Haemostasis of a Supplement of Cod-Liver Oil, Rich in Eicosapentaenoic and Docosahexaenoic Acids, in Healthy Young Men
1. Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1.8 g of eicosapentaenoic acid (20:5ω3) and 2.2 g of docosahexaenoic acid (22:6ω3). The effects of the supplement on blood lipids, haemostatic variables, bleeding time and plasma vitamin A an...
Saved in:
Published in | Clinical science (1979) Vol. 61; no. 3; pp. 317 - 324 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
01.09.1981
|
Subjects | |
Online Access | Get full text |
ISSN | 0143-5221 1470-8736 |
DOI | 10.1042/cs0610317 |
Cover
Abstract | 1. Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1.8 g of eicosapentaenoic acid (20:5ω3) and 2.2 g of docosahexaenoic acid (22:6ω3). The effects of the supplement on blood lipids, haemostatic variables, bleeding time and plasma vitamin A and carotene were studied. In seven subjects platelet aggregation induced by adenosine 5′-pyrophosphate (ADP) was also studied.
2. The proportions of 20:5ω3 and 22: 6ω3 in platelet and erythrocyte phosphoglycerides were substantially increased by the supplement mainly at the expense of ω6 polyunsaturated fatty acids.
3. Mean plasma triglyceride concentrations were reduced and those of high-density-lipoprotein (HDL) cholesterol were increased by the supplement.
4. The mean bleeding time was significantly prolonged after 3 weeks of taking the supplement, but had returned to the presupplementation value 5 weeks after withdrawal of the supplement.
5. The maximum estimated response to platelet aggregation induced by ADP was increased by the supplement.
6. The mean levels of antithrombin III (immunological) and blood pressure were lower at the end of the period of supplementation and remained so 5 weeks after withdrawal of the supplement. No significant changes in other variables were noted. |
---|---|
AbstractList | 1. Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1.8 g of eicosapentaenoic acid (20:5 omega 3) and 2.2 g of docosahexaenoic acid (22:6 omega 3). The effects of the supplement on blood lipids, haemostatic variables, bleeding time and plasma vitamin A and carotene were studied. In seven subjects platelet aggregation induced by adenosine 5'-pyrophosphate (ADP) was also studied. 2. The proportions of 20: 5 omega 3 and 22: 6 omega 3 in platelet and erythrocyte phosphoglycerides were substantially increased by the supplement mainly at the expense of omega 6 polyunsaturated fatty acids. 3. Mean plasma triglyceride concentrations were reduced and those of high-density-lipoprotein (HDL) cholesterol were increased by the supplement. 4. The mean bleeding time was significantly prolonged after 3 weeks of taking the supplement, but had returned to the presupplementation value 5 weeks after withdrawal of the supplement. 5. The maximum estimated response to platelet aggregation induced by ADP was increased by the supplement. 6. The mean levels of antithrombin III (immunological) and blood pressure were lower at the end of the period of supplementation and remained so 5 weeks after withdrawal of the supplement. No significant changes in other variables were noted.1. Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1.8 g of eicosapentaenoic acid (20:5 omega 3) and 2.2 g of docosahexaenoic acid (22:6 omega 3). The effects of the supplement on blood lipids, haemostatic variables, bleeding time and plasma vitamin A and carotene were studied. In seven subjects platelet aggregation induced by adenosine 5'-pyrophosphate (ADP) was also studied. 2. The proportions of 20: 5 omega 3 and 22: 6 omega 3 in platelet and erythrocyte phosphoglycerides were substantially increased by the supplement mainly at the expense of omega 6 polyunsaturated fatty acids. 3. Mean plasma triglyceride concentrations were reduced and those of high-density-lipoprotein (HDL) cholesterol were increased by the supplement. 4. The mean bleeding time was significantly prolonged after 3 weeks of taking the supplement, but had returned to the presupplementation value 5 weeks after withdrawal of the supplement. 5. The maximum estimated response to platelet aggregation induced by ADP was increased by the supplement. 6. The mean levels of antithrombin III (immunological) and blood pressure were lower at the end of the period of supplementation and remained so 5 weeks after withdrawal of the supplement. No significant changes in other variables were noted. Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1 multiplied by 8 g of eicosapentaenoic acid (20:5 omega 3 and 2 multiplied by 2 g of docosahexaenoic acid (22:6 omega 3). The proportions of 20:5 omega 3 and 22:6 omega 3 in platelet and erthrocyte phosphoglycerides were substantially increased by the supplement mainly at the expense of omega 6 polyunsaturated fatty acids. The mean bleeding time was significantly prolonged after 3 weeks of taking the supplement. The maximum estimated response to platelet aggregation induced by ADP was increased by the supplement. 1. Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1.8 g of eicosapentaenoic acid (20:5 omega 3) and 2.2 g of docosahexaenoic acid (22:6 omega 3). The effects of the supplement on blood lipids, haemostatic variables, bleeding time and plasma vitamin A and carotene were studied. In seven subjects platelet aggregation induced by adenosine 5'-pyrophosphate (ADP) was also studied. 2. The proportions of 20: 5 omega 3 and 22: 6 omega 3 in platelet and erythrocyte phosphoglycerides were substantially increased by the supplement mainly at the expense of omega 6 polyunsaturated fatty acids. 3. Mean plasma triglyceride concentrations were reduced and those of high-density-lipoprotein (HDL) cholesterol were increased by the supplement. 4. The mean bleeding time was significantly prolonged after 3 weeks of taking the supplement, but had returned to the presupplementation value 5 weeks after withdrawal of the supplement. 5. The maximum estimated response to platelet aggregation induced by ADP was increased by the supplement. 6. The mean levels of antithrombin III (immunological) and blood pressure were lower at the end of the period of supplementation and remained so 5 weeks after withdrawal of the supplement. No significant changes in other variables were noted. 1. Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1.8 g of eicosapentaenoic acid (20:5ω3) and 2.2 g of docosahexaenoic acid (22:6ω3). The effects of the supplement on blood lipids, haemostatic variables, bleeding time and plasma vitamin A and carotene were studied. In seven subjects platelet aggregation induced by adenosine 5′-pyrophosphate (ADP) was also studied. 2. The proportions of 20:5ω3 and 22: 6ω3 in platelet and erythrocyte phosphoglycerides were substantially increased by the supplement mainly at the expense of ω6 polyunsaturated fatty acids. 3. Mean plasma triglyceride concentrations were reduced and those of high-density-lipoprotein (HDL) cholesterol were increased by the supplement. 4. The mean bleeding time was significantly prolonged after 3 weeks of taking the supplement, but had returned to the presupplementation value 5 weeks after withdrawal of the supplement. 5. The maximum estimated response to platelet aggregation induced by ADP was increased by the supplement. 6. The mean levels of antithrombin III (immunological) and blood pressure were lower at the end of the period of supplementation and remained so 5 weeks after withdrawal of the supplement. No significant changes in other variables were noted. |
Author | Sanders, T. A. B. Haines, A. P. Vickers, Marguerite |
Author_xml | – sequence: 1 givenname: T. A. B. surname: Sanders fullname: Sanders, T. A. B. organization: Department of Nutrition, Queen Elizabeth College, University of London – sequence: 2 givenname: Marguerite surname: Vickers fullname: Vickers, Marguerite organization: MRC Epidemiology and Medical Care Unit, Northwick Park Hospital, Harrow, Middlesex, U.K – sequence: 3 givenname: A. P. surname: Haines fullname: Haines, A. P. organization: MRC Epidemiology and Medical Care Unit, Northwick Park Hospital, Harrow, Middlesex, U.K |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/6266735$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkcFO3DAQhi1EBbvQAw-A5FOlSgQ8duIkR9huWaStkEp76ClynAnrKrFD7FTlMfrG9cKKA0JCcxjNzDf_SP_Myb51Fgk5AXYOLOUX2jMJTEC-R2aQ5iwpciH3yYxBKpKMczgkc-9_M8ZFjANyILmUuchm5N-ybVEH6iy96pxr6NoMpvFU2YauFPbOB-WNp66lit5Nw9BhjzZs64VrkrX5gyO9Nd0Z_W70hhpLl0Y7r4YIKbTO6CepL27b3ODfXe9SxyNnW3yFqgubR_rLTfaefkN7TD60qvP4cZePyM-vyx-LVbK-vb5ZXK4TzUsekhx00UBaQCkLkdeprOu6BNkq2fBoBQoGnCvMkAOkNc9R8bSsS1G0aS1y3ooj8ulZdxjdw4Q-VL3xGrtOWXSTr6I9BTCAd0HIIpmVRQRPd-BU99hUw2h6NT5WO7Pj_PPzXI_O-xHbFwJYtf1j9fLHyF68YrUJKhhnw6hM98bGfx9cnd4 |
CitedBy_id | crossref_primary_10_1016_S0022_2275_20_36960_1 crossref_primary_10_1007_BF01711937 crossref_primary_10_1016_S0955_2863_01_00167_X crossref_primary_10_1079_BJN19920123 crossref_primary_10_1016_0026_0495_89_90117_0 crossref_primary_10_1016_0163_7827_86_90005_6 crossref_primary_10_1016_0261_5614_90_90022_K crossref_primary_10_1079_BJN19840009 crossref_primary_10_1023_A_1026552405042 crossref_primary_10_1111_j_1550_7408_2000_tb00002_x crossref_primary_10_1111_j_1365_2796_1990_tb00170_x crossref_primary_10_1016_0165_1838_88_90112_9 crossref_primary_10_1093_ajcn_52_1_120 crossref_primary_10_1093_ajcn_67_3_542S crossref_primary_10_1038_307165a0 crossref_primary_10_1111_j_1365_2796_1990_tb00280_x crossref_primary_10_1093_ajcn_54_2_326 crossref_primary_10_1136_bmj_293_6539_104 crossref_primary_10_1016_0005_2760_84_90209_1 crossref_primary_10_1016_S0022_2275_20_38424_8 crossref_primary_10_1155_2018_8261432 crossref_primary_10_1016_0021_9150_87_90067_0 crossref_primary_10_1161_01_ATV_17_12_3449 crossref_primary_10_1016_0006_2952_88_90218_3 crossref_primary_10_1002_ijc_2910400625 crossref_primary_10_1016_0306_9877_87_90071_5 crossref_primary_10_1016_0163_7827_86_90070_6 crossref_primary_10_1016_0049_3848_95_00152_H crossref_primary_10_5657_kfas_2002_35_2_162 crossref_primary_10_1177_0148607197021005296 crossref_primary_10_1016_S0090_6980_85_80010_1 crossref_primary_10_1016_0021_9150_85_90106_6 crossref_primary_10_1016_j_plefa_2003_11_008 crossref_primary_10_1002_lipi_19880900302 crossref_primary_10_1016_0306_3623_90_90825_7 crossref_primary_10_1111_j_1525_1594_1991_tb00768_x crossref_primary_10_1017_S1368980000000367 crossref_primary_10_1371_journal_pone_0035102 crossref_primary_10_1016_0021_9150_88_90101_3 crossref_primary_10_1016_S0952_3278_97_90421_X crossref_primary_10_1093_ajcn_46_2_258 crossref_primary_10_1111_j_1365_4362_1990_tb03477_x crossref_primary_10_3109_00365518409083785 crossref_primary_10_1007_BF00503896 crossref_primary_10_1016_0952_3278_90_90076_W crossref_primary_10_1079_NRR2005113 crossref_primary_10_1079_PNS19870048 crossref_primary_10_1016_0306_3623_90_90908_5 crossref_primary_10_1016_S0140_6736_82_91650_6 crossref_primary_10_1093_ajcn_52_1_1 crossref_primary_10_1111_j_1365_2796_1989_tb01443_x crossref_primary_10_1016_0002_9343_88_90007_1 crossref_primary_10_1007_BF02022993 crossref_primary_10_1056_NEJM198904203201603 crossref_primary_10_1080_00365518809085759 crossref_primary_10_1177_146642408410400409 crossref_primary_10_1016_0049_3848_90_90073_L crossref_primary_10_1016_S0306_9877_96_90183_8 crossref_primary_10_1016_0005_2760_88_90121_X crossref_primary_10_1016_S0006_291X_84_80193_X crossref_primary_10_1054_mehy_1997_0684 crossref_primary_10_1007_BF01622227 crossref_primary_10_1007_BF02535987 crossref_primary_10_1111_j_1751_1097_1995_tb02383_x crossref_primary_10_1016_0002_8703_87_90643_0 crossref_primary_10_1016_0049_3848_88_90054_0 crossref_primary_10_1079_BJN20051658 crossref_primary_10_1016_S0271_5317_87_80090_8 crossref_primary_10_1007_BF02534401 crossref_primary_10_1016_S0271_5317_05_80037_5 crossref_primary_10_1007_BF02536145 crossref_primary_10_1093_ajcn_65_5_1687S crossref_primary_10_1093_ajcn_59_5_1117S crossref_primary_10_1016_0049_3848_86_90101_5 crossref_primary_10_1093_ajcn_59_2_384 crossref_primary_10_1016_S0308_2261_18_30020_1 crossref_primary_10_1017_S002966519900052X crossref_primary_10_1111_j_1476_5381_1982_tb09186_x crossref_primary_10_1007_BF00496373 crossref_primary_10_1016_0021_9150_85_90021_8 crossref_primary_10_1016_S0140_6736_82_91651_8 crossref_primary_10_1007_BF02535644 crossref_primary_10_1016_0021_9150_85_90044_9 crossref_primary_10_1016_j_nutres_2004_04_008 crossref_primary_10_1016_0952_3278_94_90156_2 crossref_primary_10_1007_BF02535527 crossref_primary_10_1016_S0753_3322_02_00253_6 crossref_primary_10_1016_S0002_8223_21_01118_4 crossref_primary_10_1016_S0271_5317_85_80170_6 crossref_primary_10_1111_j_0954_6820_1986_tb03271_x crossref_primary_10_1016_S0271_5317_05_80282_9 crossref_primary_10_1016_0005_2760_87_90160_3 crossref_primary_10_1111_j_1365_2125_1990_tb03764_x crossref_primary_10_1016_S0272_6386_85_80063_9 crossref_primary_10_1016_0049_3848_91_90116_E crossref_primary_10_1016_S0950_351X_05_80085_0 crossref_primary_10_1080_00365518209168395 crossref_primary_10_2903_j_efsa_2012_2815 crossref_primary_10_1016_S0140_6736_82_91649_X crossref_primary_10_1016_0005_2760_86_90247_X crossref_primary_10_1016_0005_2736_93_90216_M crossref_primary_10_1161_JAHA_118_008757 crossref_primary_10_1111_j_1365_2621_2003_tb05730_x crossref_primary_10_1111_j_1600_0404_1990_tb01586_x crossref_primary_10_1007_BF02535267 crossref_primary_10_1016_0006_291X_83_91572_3 crossref_primary_10_1016_0021_9150_87_90049_9 crossref_primary_10_1016_S0140_6736_82_90696_1 crossref_primary_10_1016_0024_3205_88_90356_6 crossref_primary_10_1016_S0140_6736_83_92871_4 crossref_primary_10_1016_S0049_3848_00_00313_3 crossref_primary_10_1016_S0022_2275_20_34324_8 crossref_primary_10_1042_CS20040119 crossref_primary_10_1021_acs_molpharmaceut_8b01065 crossref_primary_10_1186_s41043_023_00489_w crossref_primary_10_1007_BF00844780 crossref_primary_10_1016_0021_9150_91_90081_D crossref_primary_10_7759_cureus_15556 crossref_primary_10_1016_j_atherosclerosis_2004_10_010 crossref_primary_10_1016_S0022_3476_05_81666_X crossref_primary_10_1007_BF02534720 crossref_primary_10_1093_ajcn_52_2_300 crossref_primary_10_1056_NEJM198604103141501 crossref_primary_10_1038_ki_1984_137 crossref_primary_10_1093_jn_133_7_2210 crossref_primary_10_1111_j_1753_4887_1989_tb02754_x crossref_primary_10_1111_j_1753_4887_1986_tb07603_x crossref_primary_10_1136_ard_45_12_1019 crossref_primary_10_1007_BF00915039 crossref_primary_10_1007_BF00877326 crossref_primary_10_1007_s11745_997_0089_x crossref_primary_10_1016_0049_3848_89_90137_0 crossref_primary_10_1056_NEJM198809223191201 crossref_primary_10_1046_j_1365_201X_2003_01139_x crossref_primary_10_1016_0163_7827_92_90009_8 crossref_primary_10_1111_j_0954_6820_1983_tb03705_x crossref_primary_10_1093_ajcn_54_4_689 crossref_primary_10_1111_j_1365_2796_1989_tb01442_x crossref_primary_10_1079_PNS19850064 crossref_primary_10_1017_S0007114598001068 crossref_primary_10_1016_0952_3278_93_90184_X crossref_primary_10_1111_j_1749_6632_1997_tb51845_x crossref_primary_10_1016_S0271_5317_83_80095_5 crossref_primary_10_1016_0049_3848_84_90249_4 crossref_primary_10_1079_BJN19940109 crossref_primary_10_1093_ajcn_54_3_438 crossref_primary_10_1016_0021_9150_85_90091_7 crossref_primary_10_1002_art_1780290412 crossref_primary_10_1016_S0022_2275_20_38310_3 crossref_primary_10_1111_j_1365_2796_1991_tb00353_x crossref_primary_10_1016_S0271_5317_05_80344_6 crossref_primary_10_1007_BF02535173 crossref_primary_10_1016_S0889_8529_18_30328_1 crossref_primary_10_1016_0049_3848_90_90069_O crossref_primary_10_1177_014860719301700130 crossref_primary_10_1079_BJN19920074 crossref_primary_10_1016_0952_3278_93_90074_7 crossref_primary_10_1079_BJN19880070 crossref_primary_10_1016_S0140_6736_87_90502_2 crossref_primary_10_1093_ajcn_43_4_566 crossref_primary_10_1016_S0025_6196_12_61879_5 crossref_primary_10_1016_0026_0495_95_90111_6 crossref_primary_10_1016_S0378_4347_00_80630_1 crossref_primary_10_1007_s00276_020_02596_3 crossref_primary_10_1093_ajcn_87_4_912 crossref_primary_10_1093_jn_118_6_661 crossref_primary_10_1016_0005_2760_95_00043_C crossref_primary_10_1016_0952_3278_93_90112_A crossref_primary_10_2740_jisdh_22_277 crossref_primary_10_1007_BF01966147 crossref_primary_10_1093_ajcn_55_3_760a crossref_primary_10_1016_S0021_9150_98_00233_0 crossref_primary_10_1093_ajcn_54_4_668 crossref_primary_10_1111_j_1432_1033_1991_tb15842_x crossref_primary_10_1016_0009_8981_87_90306_8 crossref_primary_10_1111_j_1365_2796_1989_tb01447_x crossref_primary_10_1111_j_1445_5994_1988_tb00160_x crossref_primary_10_1016_0049_3848_82_90112_8 crossref_primary_10_1007_BF02637095 crossref_primary_10_1007_BF02005181 crossref_primary_10_1111_nure_12071 crossref_primary_10_1016_0306_9877_87_90102_2 crossref_primary_10_1007_BF01622867 crossref_primary_10_1016_0021_9150_91_90233_S crossref_primary_10_1007_BF02536438 crossref_primary_10_1016_0006_2952_94_90118_X crossref_primary_10_1016_0006_2952_91_90445_B crossref_primary_10_1111_j_1365_2141_1984_tb06103_x crossref_primary_10_1111_j_1445_5994_1984_tb03613_x crossref_primary_10_1093_ajcn_39_6_975 crossref_primary_10_1007_BF01907412 crossref_primary_10_1016_0305_0491_89_90225_3 crossref_primary_10_1007_BF02542556 crossref_primary_10_1016_0735_1097_93_90357_7 crossref_primary_10_1016_S0271_5317_85_80016_6 crossref_primary_10_1016_S0022_5223_19_38784_7 crossref_primary_10_1016_0005_2760_86_90266_3 crossref_primary_10_1016_S0952_3278_96_90072_1 crossref_primary_10_1111_j_1365_2796_1989_tb01436_x crossref_primary_10_1016_0002_9149_90_91093_L crossref_primary_10_1056_NEJM198610023151401 crossref_primary_10_1016_S0005_2760_97_00194_X crossref_primary_10_1016_S0140_6736_89_90370_X crossref_primary_10_1177_1060028087021007_803 crossref_primary_10_1056_NEJM199003223221202 crossref_primary_10_1016_0049_3848_90_90190_N crossref_primary_10_1016_S0006_291X_83_80254_X crossref_primary_10_1016_0026_0495_83_90226_3 crossref_primary_10_1002_ajh_2830240205 crossref_primary_10_1079_BJN19830123 crossref_primary_10_1093_jn_120_4_325 crossref_primary_10_1007_BF02536337 crossref_primary_10_1016_0090_6980_86_90123_1 crossref_primary_10_1080_07315724_1989_10720312 crossref_primary_10_1016_S0022_2275_20_37132_7 crossref_primary_10_1079_BJN19840069 crossref_primary_10_3390_sports7070167 crossref_primary_10_1093_ajcn_57_1_59 crossref_primary_10_1016_S0006_2952_96_00734_4 crossref_primary_10_1016_j_plipres_2008_03_003 crossref_primary_10_1111_j_1365_2796_1989_tb01448_x crossref_primary_10_1016_0005_2760_92_90058_4 crossref_primary_10_1093_ajcn_46_3_424 crossref_primary_10_1007_BF00264763 crossref_primary_10_1007_BF02536338 crossref_primary_10_1093_jn_117_6_1011 crossref_primary_10_1007_BF01907750 crossref_primary_10_1016_0026_0495_85_90135_0 crossref_primary_10_1079_PNS19970049 crossref_primary_10_1111_j_1749_6632_1992_tb17102_x crossref_primary_10_1136_hrt_57_3_214 crossref_primary_10_1016_0952_3278_91_90191_7 crossref_primary_10_1016_S0003_4975_10_64496_7 crossref_primary_10_1007_BF02536203 crossref_primary_10_1007_BF02533970 crossref_primary_10_1111_j_1440_1681_1991_tb01442_x crossref_primary_10_3390_nu16091261 crossref_primary_10_1185_03007999309111542 crossref_primary_10_2740_jisdh_23_77 crossref_primary_10_1016_0006_291X_88_90737_1 crossref_primary_10_1002_bms_1200120905 crossref_primary_10_1016_0021_9150_87_90113_4 crossref_primary_10_1007_BF02522617 crossref_primary_10_1016_0091_7435_91_90065_C |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7U7 C1K 7X8 |
DOI | 10.1042/cs0610317 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Toxicology Abstracts MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1470-8736 |
EndPage | 324 |
ExternalDocumentID | 6266735 10_1042_cs0610317 |
Genre | Journal Article |
GroupedDBID | --- .55 .GJ 0R~ 0VX 3O- 53G 5GY 5RE 5VS 6J9 AAYXX ABCQX ABJNI ACGFO ACGFS AEGXH AENEX AFFNX AI. AIAGR AIZAD ALMA_UNASSIGNED_HOLDINGS CITATION CS3 DU5 EBS EJD F5P GX1 H13 HZ~ L7B MVM O9- OHT P2P RHI RPO VH1 WH7 X7M ZGI ZXP 29B 2WC 4.4 AABGO AAHRG ADBBV AFFVI BAWUL CGR CUY CVF E3Z EBD ECM EIF EMOBN MV1 NPM NTEUP P6G SV3 TR2 7U7 C1K 7X8 |
ID | FETCH-LOGICAL-c292t-71c8d148196837b46bbb916fa6d2103e30122ae5e2114b27ea249b938f4b372f3 |
ISSN | 0143-5221 |
IngestDate | Fri Jul 11 07:06:22 EDT 2025 Fri Jul 11 07:41:10 EDT 2025 Sat Sep 28 08:34:27 EDT 2024 Thu Apr 24 23:05:27 EDT 2025 Tue Jul 01 03:56:56 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c292t-71c8d148196837b46bbb916fa6d2103e30122ae5e2114b27ea249b938f4b372f3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 6266735 |
PQID | 15358598 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_73581011 proquest_miscellaneous_15358598 pubmed_primary_6266735 crossref_primary_10_1042_cs0610317 crossref_citationtrail_10_1042_cs0610317 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 1981-Sep |
PublicationDateYYYYMMDD | 1981-09-01 |
PublicationDate_xml | – month: 09 year: 1981 text: 1981-Sep |
PublicationDecade | 1980 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Clinical science (1979) |
PublicationTitleAlternate | Clin Sci (Lond) |
PublicationYear | 1981 |
SSID | ssj0023232 |
Score | 1.5223904 |
Snippet | 1. Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1.8 g of eicosapentaenoic acid (20:5ω3) and 2.2 g... 1. Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1.8 g of eicosapentaenoic acid (20:5 omega 3) and... Twelve healthy male subjects took a daily supplement of 20 ml of cod-liver oil for 6 weeks. This provided 1 multiplied by 8 g of eicosapentaenoic acid (20:5... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 317 |
SubjectTerms | Adult Bleeding Time Blood Platelets - metabolism Carotenoids - blood Cholesterol - blood Cod Liver Oil - pharmacology Docosahexaenoic Acids Eicosanoic Acids - pharmacology Eicosapentaenoic Acid Erythrocytes - metabolism Fatty Acids, Unsaturated - pharmacology Fish Oils - pharmacology Glycerophosphates - blood Hemostasis - drug effects Humans Lipids - blood Male Platelet Aggregation - drug effects Triglycerides - blood Vitamin A - blood |
Title | Effect on Blood Lipids and Haemostasis of a Supplement of Cod-Liver Oil, Rich in Eicosapentaenoic and Docosahexaenoic Acids, in Healthy Young Men |
URI | https://www.ncbi.nlm.nih.gov/pubmed/6266735 https://www.proquest.com/docview/15358598 https://www.proquest.com/docview/73581011 |
Volume | 61 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSIgL4lWxPC3EASkNNLY3j2OFWipUyoFdtLfIThw10jZZka3U9l_wj_n8SHa3tOJxiXYdx4k8n8bzjWfGhLwts1RFlcrCkgsRinSchlKLJIzSqoxYpc2iYqItjuPDqfg8G89W8fM2u2Sp3heX1-aV_I9U0Qa5mizZf5DsMCga8BvyxRUSxvWvZOxLD0OANv48mNeLunRFl0-kPm1h-fl6IzLozPGdut_6L9oynJuQjKB1TmCoQ-v70EBGJxcmolw3rS_mWram8USf920FXmOewgMukfIiuDBqIzj1mWV97YONvMvC2rNRlmRr_odvLr3G4mblWP1em3CPbtNdK2t_rsCez0orXfpeGg3hWCsHJgf5dVnRvQaOozWk8TV1yl1e529qHpoGsik6GCO7vs9mKe3jr_nB9Ogon-zPJrfJHZYkdg__02yI_4ElaU-vGz6oLzsl2Idh4E1j5QYGYi2RyQNy31MIuufw8JDc0s0jcveLD5J4TH46WNC2oRYW1MGCYqLpGixoW1FJV7Aw_wdYUMBihxpQ0LqhV0Fhh7oCCmpBsWO6e0hQCwmKsZ-Q6cH-5ONh6E_eCAuWsWWYREVagihDPac8USJWSoFHVDIuGSZGc7MhK_VYM9BpxRItweJVxtNKKJ6wim-TraZt9FNCdQoGjvsMVEMYvhBzHWcizhTXoEzViLzrpzgvfFl6czrKPLfhEYLlgzRG5M3QdeFqsVzX6XUvpxya0mx_yUa3Z12OtR3cOEtv7pGYYoBY8EZk2wl4eA1of4y7z_746HNybwX7F2Rr-eNMv4TZulSvLPx-AbD9mhw |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+on+blood+lipids+and+haemostasis+of+a+supplement+of+cod-liver+oil%2C+rich+in+eicosapentaenoic+and+docosahexaenoic+acids%2C+in+healthy+young+men&rft.jtitle=Clinical+science+%281979%29&rft.au=Sanders%2C+T+A&rft.au=Vickers%2C+M&rft.au=Haines%2C+A+P&rft.date=1981-09-01&rft.issn=0143-5221&rft.volume=61&rft.issue=3&rft.spage=317&rft_id=info:doi/10.1042%2Fcs0610317&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0143-5221&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0143-5221&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0143-5221&client=summon |